vs
Organogenesis Holdings Inc.（ORGO）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是REDWOOD TRUST INC的8.7倍（$225.6M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs 19.4%，领先57.9%），Organogenesis Holdings Inc.同比增速更快（78.1% vs -6.1%），过去两年Organogenesis Holdings Inc.的营收复合增速更高（43.2% vs -41.0%）
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
ORGO vs RWT — 直观对比
营收规模更大
ORGO
是对方的8.7倍
$25.9M
营收增速更快
ORGO
高出84.2%
-6.1%
净利率更高
RWT
高出57.9%
19.4%
两年增速更快
ORGO
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $225.6M | $25.9M |
| 净利润 | $43.7M | $20.0M |
| 毛利率 | — | — |
| 营业利润率 | 28.1% | — |
| 净利率 | 19.4% | 77.2% |
| 营收同比 | 78.1% | -6.1% |
| 净利润同比 | 469.5% | 402.6% |
| 每股收益（稀释后） | $0.31 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ORGORWT
| Q4 25 | $225.6M | $25.9M | ||
| Q3 25 | $150.9M | $15.0M | ||
| Q2 25 | $101.0M | $13.8M | ||
| Q1 25 | $86.7M | $27.9M | ||
| Q4 24 | $126.7M | $27.6M | ||
| Q3 24 | $115.2M | $25.5M | ||
| Q2 24 | $130.2M | $67.4M | ||
| Q1 24 | $110.0M | $74.5M |
净利润ORGORWT
| Q4 25 | $43.7M | $20.0M | ||
| Q3 25 | $21.6M | $-7.7M | ||
| Q2 25 | $-9.4M | $-98.5M | ||
| Q1 25 | $-18.8M | $16.1M | ||
| Q4 24 | $7.7M | $-6.6M | ||
| Q3 24 | $12.3M | $14.8M | ||
| Q2 24 | $-17.0M | $15.5M | ||
| Q1 24 | $-2.1M | $30.3M |
毛利率ORGORWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 72.6% | — | ||
| Q4 24 | 75.5% | — | ||
| Q3 24 | 76.7% | — | ||
| Q2 24 | 77.6% | — | ||
| Q1 24 | 73.9% | — |
营业利润率ORGORWT
| Q4 25 | 28.1% | — | ||
| Q3 25 | 13.7% | -9.0% | ||
| Q2 25 | -12.5% | -679.0% | ||
| Q1 25 | -30.9% | 80.2% | ||
| Q4 24 | 8.1% | -1.3% | ||
| Q3 24 | 5.4% | 86.1% | ||
| Q2 24 | -10.7% | 30.3% | ||
| Q1 24 | -3.5% | 41.3% |
净利率ORGORWT
| Q4 25 | 19.4% | 77.2% | ||
| Q3 25 | 14.3% | -51.4% | ||
| Q2 25 | -9.3% | -712.0% | ||
| Q1 25 | -21.7% | 57.8% | ||
| Q4 24 | 6.1% | -24.0% | ||
| Q3 24 | 10.7% | 58.1% | ||
| Q2 24 | -13.1% | 23.0% | ||
| Q1 24 | -1.9% | 40.6% |
每股收益（稀释后）ORGORWT
| Q4 25 | $0.31 | $0.11 | ||
| Q3 25 | $0.11 | $-0.08 | ||
| Q2 25 | $-0.10 | $-0.76 | ||
| Q1 25 | $-0.17 | $0.10 | ||
| Q4 24 | $0.05 | $-0.08 | ||
| Q3 24 | $0.09 | $0.09 | ||
| Q2 24 | $-0.13 | $0.10 | ||
| Q1 24 | $-0.02 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.7M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $300.1M | $982.6M |
| 总资产 | $598.7M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ORGORWT
| Q4 25 | $93.7M | $255.7M | ||
| Q3 25 | $63.7M | $226.3M | ||
| Q2 25 | $73.1M | $302.0M | ||
| Q1 25 | $110.0M | $259.9M | ||
| Q4 24 | $135.6M | $245.2M | ||
| Q3 24 | $94.3M | $253.7M | ||
| Q2 24 | $89.9M | $275.6M | ||
| Q1 24 | $88.6M | $275.4M |
总债务ORGORWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — | ||
| Q1 24 | $65.2M | $1.7B |
股东权益ORGORWT
| Q4 25 | $300.1M | $982.6M | ||
| Q3 25 | $255.1M | $999.0M | ||
| Q2 25 | $233.2M | $1.1B | ||
| Q1 25 | $242.9M | $1.2B | ||
| Q4 24 | $262.9M | $1.2B | ||
| Q3 24 | $278.5M | $1.2B | ||
| Q2 24 | $263.5M | $1.2B | ||
| Q1 24 | $278.0M | $1.2B |
总资产ORGORWT
| Q4 25 | $598.7M | $23.7B | ||
| Q3 25 | $509.8M | $22.6B | ||
| Q2 25 | $461.1M | $21.3B | ||
| Q1 25 | $467.4M | $19.9B | ||
| Q4 24 | $497.9M | $18.3B | ||
| Q3 24 | $446.3M | $18.4B | ||
| Q2 24 | $443.2M | $16.5B | ||
| Q1 24 | $458.5M | $15.1B |
负债/权益比ORGORWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.23× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.4M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $34.8M | — |
| 自由现金流率自由现金流/营收 | 15.4% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | 0.90× | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-24.5M | — |
8季度趋势，按日历期对齐
经营现金流ORGORWT
| Q4 25 | $39.4M | $-10.1B | ||
| Q3 25 | $3.1M | $-2.7B | ||
| Q2 25 | $-32.9M | $-2.1B | ||
| Q1 25 | $-19.9M | $-2.0B | ||
| Q4 24 | $10.9M | $-5.9B | ||
| Q3 24 | $8.7M | $-2.1B | ||
| Q2 24 | $4.7M | $-2.0B | ||
| Q1 24 | $-10.2M | $-954.2M |
自由现金流ORGORWT
| Q4 25 | $34.8M | — | ||
| Q3 25 | $844.0K | — | ||
| Q2 25 | $-36.5M | — | ||
| Q1 25 | $-23.6M | — | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $-12.4M | — |
自由现金流率ORGORWT
| Q4 25 | 15.4% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -36.1% | — | ||
| Q1 25 | -27.2% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | -11.3% | — |
资本支出强度ORGORWT
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.0% | — |
现金转化率ORGORWT
| Q4 25 | 0.90× | -504.15× | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 0.71× | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
